Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

Experimental drug (Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg)

Acne Vulgaris

PhasePhase 3
StatusRECRUITING
SponsorUnknown
Enrolment531
Primary completion2027-03
Primary endpointAbsolute reduction from baseline in the number of inflammatory acne lesions assessed at Cycle 6.
Registry IDNCT06905210

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:31:53.068Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT06905210

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
Experimental drug (Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg) — trial | AEaH